Fractal dimension: analyzing its potential as a neuroimaging biomarker for brain tumor diagnosis using machine learning

Purpose: The main purpose of this study was to comprehensively investigate the potential of fractal dimension (FD) measures in discriminating brain gliomas into low-grade glioma (LGG) and high-grade glioma (HGG) by examining tumor constituents and non-tumorous gray matter (GM) and white matter (WM) regions. Methods: Retrospective magnetic resonance imaging (MRI) data of 42 glioma patients (LGG, n = 27 and HGG, n = 15) were used in this study. Using MRI, we calculated different FD measures based on the general structure, boundary, and skeleton aspects of the tumorous and non-tumorous brain GM and WM regions. Texture features, namely, angular second moment, contrast, inverse difference moment, correlation, and entropy, were also measured in the tumorous and non-tumorous regions. The efficacy of FD features was assessed by comparing them with texture features. Statistical inference and machine learning approaches were used on the aforementioned measures to distinguish LGG and HGG patients. Results: FD measures from tumorous and non-tumorous regions were able to distinguish LGG and HGG patients. Among the 15 different FD measures, the general structure FD values of enhanced tumor regions yielded high accuracy (93%), sensitivity (97%), specificity (98%), and area under the receiver operating characteristic curve (AUC) score (98%). Non-tumorous GM skeleton FD values also yielded good accuracy (83.3%), sensitivity (100%), specificity (60%), and AUC score (80%) in classifying the tumor grades. These measures were also found to be significantly (p < 0.05) different between LGG and HGG patients. On the other hand, among the 25 texture features, enhanced tumor region features, namely, contrast, correlation, and entropy, revealed significant differences between LGG and HGG. In machine learning, the enhanced tumor region texture features yielded high accuracy, sensitivity, specificity, and AUC score. Conclusion: A comparison between texture and FD features revealed that FD analysis on different aspects of the tumorous and non-tumorous components not only distinguished LGG and HGG patients with high statistical significance and classification accuracy but also provided better insights into glioma grade classification. Therefore, FD features can serve as potential neuroimaging biomarkers for glioma.

[1]  M. Martin-Landrove,et al.  Morphological and Fractal Properties of Brain Tumors , 2022, Frontiers in Physiology.

[2]  R. Appay,et al.  [The 2021 WHO classification of tumours of the central nervous system]. , 2021, Annales de pathologie.

[3]  A. Alexiou,et al.  BrainFD: Measuring the Intracranial Brain Volume With Fractal Dimension , 2021, Frontiers in Aging Neuroscience.

[4]  Y. Nishiyama,et al.  Fractal analysis of 11C-methionine PET in patients with newly diagnosed glioma , 2021, EJNMMI Physics.

[5]  Eduardo Moreno-Barbosa,et al.  A simple model for glioma grading based on texture analysis applied to conventional brain MRI , 2020, bioRxiv.

[6]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. , 2019, Neuro-oncology.

[7]  I. Pollack,et al.  Childhood brain tumors: current management, biological insights, and future directions. , 2019, Journal of neurosurgery. Pediatrics.

[8]  N. Kavantzas,et al.  The Goodness-of-fit of the Fractal Dimension as a Diagnostic Factor in Breast Cancer , 2018, Cureus.

[9]  D. Lu,et al.  Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973‐2014 , 2018, Cancer medicine.

[10]  J. McFaline-Figueroa,et al.  Brain Tumors. , 2018, The American journal of medicine.

[11]  T. Chenevert,et al.  Brain Tumor Characterization Using Multibiometric Evaluation of MRI , 2018, Tomography.

[12]  Goutam Sanyal,et al.  Brain MR Image Analysis using Discrete wavelet Transform with Fractal Feature Analysis , 2018, 2018 Second International Conference on Electronics, Communication and Aerospace Technology (ICECA).

[13]  Kumar Rajamani,et al.  Robust classification of MR brain images based on fractal dimension analysis , 2017, 2017 International Conference on Advances in Computing, Communications and Informatics (ICACCI).

[14]  Yang Yang,et al.  Optimizing a machine learning based glioma grading system using multi-parametric MRI histogram and texture features , 2017, Oncotarget.

[15]  B. V. V. S. N. Prabhakar Rao,et al.  Volumetric analysis of MR images for glioma classification and their effect on brain tissues , 2017, Signal Image Video Process..

[16]  Pierre-Jean Le Reste,et al.  Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging. , 2016, Neurosurgery.

[17]  G. Armstrong,et al.  Hypothalamic-Pituitary Axis Dysfunction in Survivors of Childhood CNS Tumors: Importance of Systematic Follow-Up and Early Endocrine Consultation. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Merchant,et al.  Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Yudong Zhang,et al.  Fractal Dimension Estimation for Developing Pathological Brain Detection System Based on Minkowski-Bouligand Method , 2016, IEEE Access.

[20]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[21]  B. Ganeshan,et al.  Diagnostic performance of texture analysis on MRI in grading cerebral gliomas. , 2016, European journal of radiology.

[22]  Ş. Arslan,et al.  Magnetic Resonance Imaging May Be a Valuable Radiation-Free Technique for Lung Pathologies in Patients with Primary Immunodeficiency , 2015, Journal of Clinical Immunology.

[23]  R. Jayasree,et al.  Fractal analysis: fractal dimension and lacunarity from MR images for differentiating the grades of glioma , 2015, Physics in medicine and biology.

[24]  Omar S. Al-Kadi,et al.  A Multiresolution Clinical Decision Support System Based on Fractal Model Design for Classification of Histological Brain Tumours , 2015, Comput. Medical Imaging Graph..

[25]  Malcolm A. Smith,et al.  Remaining challenges in childhood cancer and newer targeted therapeutics. , 2015, Pediatric clinics of North America.

[26]  Low-grade gliomas. , 2014, The oncologist.

[27]  K. Aldape,et al.  A randomized trial of bevacizumab for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[28]  K. Hoang-Xuan,et al.  Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[29]  Guang H. Yue,et al.  Brain White Matter Shape Changes in Amyotrophic Lateral Sclerosis (ALS): A Fractal Dimension Study , 2013, PloS one.

[30]  Christos Davatzikos,et al.  Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme , 2009, Magnetic resonance in medicine.

[31]  Brandon Whitcher,et al.  Quantifying spatial heterogeneity in dynamic contrast‐enhanced MRI parameter maps , 2009, Magnetic resonance in medicine.

[32]  Nacim Betrouni,et al.  Fractal and multifractal analysis: A review , 2009, Medical Image Anal..

[33]  Guang H. Yue,et al.  Fractal dimension assessment of brain white matter structural complexity post stroke in relation to upper-extremity motor function , 2008, Brain Research.

[34]  P. Desmond,et al.  Diffusion Tensor Imaging in Glioblastoma Multiforme and Brain Metastases: The Role of p, q, L, and Fractional Anisotropy , 2008, American Journal of Neuroradiology.

[35]  Jinyuan Zhou,et al.  Evaluation of human brain tumor heterogeneity using multiple T1‐based MRI signal weighting approaches , 2008, Magnetic resonance in medicine.

[36]  Guang H. Yue,et al.  Quantifying degeneration of white matter in normal aging using fractal dimension , 2007, Neurobiology of Aging.

[37]  Joaquín Goñi,et al.  Fractal dimension and white matter changes in multiple sclerosis , 2007, NeuroImage.

[38]  Jing Z. Liu,et al.  A three-dimensional fractal analysis method for quantifying white matter structure in human brain , 2006, Journal of Neuroscience Methods.

[39]  Jing Z. Liu,et al.  Fractal dimension in human cerebellum measured by magnetic resonance imaging. , 2003, Biophysical journal.

[40]  Ronald Marsh,et al.  Fractal analysis of tumor in brain MR images , 2003, Machine Vision and Applications.

[41]  Mark E Bastin,et al.  Diffusion tensor MR imaging of high-grade cerebral gliomas. , 2002, AJNR. American journal of neuroradiology.

[42]  S. Strother,et al.  The Quantitative Evaluation of Functional Neuroimaging Experiments: Mutual Information Learning Curves , 2002, NeuroImage.

[43]  S. Torquato,et al.  Pattern of self‐organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model , 2001, Cell proliferation.

[44]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.

[45]  L. Recht,et al.  Low-grade gliomas. , 1995, Neurologic clinics.

[46]  Benoit B. Mandelbrot,et al.  Fractal Geometry of Nature , 1984 .

[47]  Salim Lahmiri,et al.  Glioma detection based on multi-fractal features of segmented brain MRI by particle swarm optimization techniques , 2017, Biomed. Signal Process. Control..

[48]  H. Girish,et al.  Risk of tumor cell seeding through biopsy and aspiration cytology , 2014, Journal of International Society of Preventive & Community Dentistry.

[49]  C. Kruchko,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.

[50]  Min Tang,et al.  Feature Analysis of Brain MRI Images Based on Fractal Dimension , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.

[51]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.